nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—Pioglitazone—type 2 diabetes mellitus	0.288	1	CrCtD
Rosiglitazone—Thiazolidinediones—Pioglitazone—type 2 diabetes mellitus	0.124	0.333	CiPCiCtD
Rosiglitazone—PPAR gamma—Pioglitazone—type 2 diabetes mellitus	0.124	0.333	CiPCiCtD
Rosiglitazone—Peroxisome Proliferator-activated Receptor Activity—Pioglitazone—type 2 diabetes mellitus	0.124	0.333	CiPCiCtD
Rosiglitazone—PPARG—type 2 diabetes mellitus	0.0468	0.493	CbGaD
Rosiglitazone—CYP1A2—type 2 diabetes mellitus	0.0305	0.321	CbGaD
Rosiglitazone—PPARG—Glipizide—type 2 diabetes mellitus	0.0213	0.127	CbGbCtD
Rosiglitazone—PPARG—Repaglinide—type 2 diabetes mellitus	0.0186	0.111	CbGbCtD
Rosiglitazone—ALB—type 2 diabetes mellitus	0.0176	0.186	CbGaD
Rosiglitazone—PPARG—Pioglitazone—type 2 diabetes mellitus	0.0169	0.1	CbGbCtD
Rosiglitazone—PPARG—Nateglinide—type 2 diabetes mellitus	0.0128	0.0761	CbGbCtD
Rosiglitazone—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.00641	0.0381	CbGbCtD
Rosiglitazone—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.00579	0.0345	CbGbCtD
Rosiglitazone—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.00472	0.0281	CbGbCtD
Rosiglitazone—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.00425	0.0253	CbGbCtD
Rosiglitazone—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.00425	0.0253	CbGbCtD
Rosiglitazone—ALB—Gliclazide—type 2 diabetes mellitus	0.00373	0.0222	CbGbCtD
Rosiglitazone—ALB—Repaglinide—type 2 diabetes mellitus	0.00351	0.0209	CbGbCtD
Rosiglitazone—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.00339	0.0202	CbGbCtD
Rosiglitazone—PTGS1—Nateglinide—type 2 diabetes mellitus	0.00322	0.0192	CbGbCtD
Rosiglitazone—PTGS1—Irbesartan—type 2 diabetes mellitus	0.00309	0.0184	CbGbCtD
Rosiglitazone—SLCO1B1—Losartan—type 2 diabetes mellitus	0.00271	0.0161	CbGbCtD
Rosiglitazone—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.00271	0.0161	CbGbCtD
Rosiglitazone—ALB—Valsartan—type 2 diabetes mellitus	0.00259	0.0154	CbGbCtD
Rosiglitazone—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.00245	0.0146	CbGbCtD
Rosiglitazone—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00242	0.0144	CbGbCtD
Rosiglitazone—ALB—Nateglinide—type 2 diabetes mellitus	0.0024	0.0143	CbGbCtD
Rosiglitazone—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00237	0.0141	CbGbCtD
Rosiglitazone—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.00219	0.013	CbGbCtD
Rosiglitazone—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00216	0.0129	CbGbCtD
Rosiglitazone—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00206	0.0122	CbGbCtD
Rosiglitazone—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00206	0.0122	CbGbCtD
Rosiglitazone—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00201	0.012	CbGbCtD
Rosiglitazone—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00183	0.0109	CbGbCtD
Rosiglitazone—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00178	0.0106	CbGbCtD
Rosiglitazone—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00171	0.0102	CbGbCtD
Rosiglitazone—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00171	0.0102	CbGbCtD
Rosiglitazone—ALB—Glyburide—type 2 diabetes mellitus	0.00162	0.00967	CbGbCtD
Rosiglitazone—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00156	0.00931	CbGbCtD
Rosiglitazone—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00152	0.00907	CbGbCtD
Rosiglitazone—ALB—Losartan—type 2 diabetes mellitus	0.00149	0.00884	CbGbCtD
Rosiglitazone—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00139	0.0083	CbGbCtD
Rosiglitazone—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00138	0.00821	CbGbCtD
Rosiglitazone—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0013	0.00776	CbGbCtD
Rosiglitazone—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0013	0.00772	CbGbCtD
Rosiglitazone—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00124	0.0074	CbGbCtD
Rosiglitazone—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00119	0.00705	CbGbCtD
Rosiglitazone—CYP2C8—Losartan—type 2 diabetes mellitus	0.00115	0.00683	CbGbCtD
Rosiglitazone—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00114	0.00676	CbGbCtD
Rosiglitazone—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00105	0.00627	CbGbCtD
Rosiglitazone—CYP2C19—Losartan—type 2 diabetes mellitus	0.000963	0.00573	CbGbCtD
Rosiglitazone—PPARG—brown adipose tissue—type 2 diabetes mellitus	0.0009	0.113	CbGeAlD
Rosiglitazone—CYP1A2—Losartan—type 2 diabetes mellitus	0.000889	0.00529	CbGbCtD
Rosiglitazone—CYP2C9—Glyburide—type 2 diabetes mellitus	0.000876	0.00521	CbGbCtD
Rosiglitazone—CYP2C9—Losartan—type 2 diabetes mellitus	0.000801	0.00477	CbGbCtD
Rosiglitazone—PPARG—leg—type 2 diabetes mellitus	0.000724	0.091	CbGeAlD
Rosiglitazone—PPARG—hindlimb—type 2 diabetes mellitus	0.000647	0.0813	CbGeAlD
Rosiglitazone—ACSL4—islet of Langerhans—type 2 diabetes mellitus	0.000423	0.0532	CbGeAlD
Rosiglitazone—PPARG—artery—type 2 diabetes mellitus	0.000396	0.0498	CbGeAlD
Rosiglitazone—ACSL4—retina—type 2 diabetes mellitus	0.000362	0.0455	CbGeAlD
Rosiglitazone—ACSL4—nephron tubule—type 2 diabetes mellitus	0.000341	0.0429	CbGeAlD
Rosiglitazone—PPARG—endothelium—type 2 diabetes mellitus	0.000335	0.0421	CbGeAlD
Rosiglitazone—ACSL4—cardiovascular system—type 2 diabetes mellitus	0.000306	0.0385	CbGeAlD
Rosiglitazone—ACSL4—pancreas—type 2 diabetes mellitus	0.000298	0.0374	CbGeAlD
Rosiglitazone—Pioglitazone—PPARG—type 2 diabetes mellitus	0.000294	0.531	CrCbGaD
Rosiglitazone—ACSL4—cortex of kidney—type 2 diabetes mellitus	0.000292	0.0367	CbGeAlD
Rosiglitazone—ACSL4—adipose tissue—type 2 diabetes mellitus	0.00027	0.0339	CbGeAlD
Rosiglitazone—PTGS1—artery—type 2 diabetes mellitus	0.000212	0.0266	CbGeAlD
Rosiglitazone—PPARG—islet of Langerhans—type 2 diabetes mellitus	0.00019	0.0239	CbGeAlD
Rosiglitazone—ACSL4—liver—type 2 diabetes mellitus	0.000189	0.0238	CbGeAlD
Rosiglitazone—PTGS1—endothelium—type 2 diabetes mellitus	0.000179	0.0225	CbGeAlD
Rosiglitazone—SLCO1B1—kidney—type 2 diabetes mellitus	0.000156	0.0196	CbGeAlD
Rosiglitazone—CYP2A6—adipose tissue—type 2 diabetes mellitus	0.000143	0.0179	CbGeAlD
Rosiglitazone—PPARG—cardiovascular system—type 2 diabetes mellitus	0.000138	0.0173	CbGeAlD
Rosiglitazone—PPARG—kidney—type 2 diabetes mellitus	0.000135	0.0169	CbGeAlD
Rosiglitazone—PPARG—pancreas—type 2 diabetes mellitus	0.000134	0.0168	CbGeAlD
Rosiglitazone—Dofetilide—CYP3A4—type 2 diabetes mellitus	0.000133	0.24	CrCbGaD
Rosiglitazone—Pioglitazone—CYP3A4—type 2 diabetes mellitus	0.000127	0.229	CrCbGaD
Rosiglitazone—PPARG—adipose tissue—type 2 diabetes mellitus	0.000121	0.0153	CbGeAlD
Rosiglitazone—CYP2A6—liver—type 2 diabetes mellitus	0.0001	0.0126	CbGeAlD
Rosiglitazone—SLCO1B1—liver—type 2 diabetes mellitus	9.88e-05	0.0124	CbGeAlD
Rosiglitazone—CYP2C8—kidney—type 2 diabetes mellitus	8.88e-05	0.0112	CbGeAlD
Rosiglitazone—PPARG—liver—type 2 diabetes mellitus	8.52e-05	0.0107	CbGeAlD
Rosiglitazone—CYP2C9—cardiovascular system—type 2 diabetes mellitus	8.07e-05	0.0101	CbGeAlD
Rosiglitazone—ALB—liver—type 2 diabetes mellitus	7.99e-05	0.01	CbGeAlD
Rosiglitazone—PTGS1—cardiovascular system—type 2 diabetes mellitus	7.36e-05	0.00926	CbGeAlD
Rosiglitazone—PTGS1—kidney—type 2 diabetes mellitus	7.2e-05	0.00906	CbGeAlD
Rosiglitazone—PTGS1—adipose tissue—type 2 diabetes mellitus	6.49e-05	0.00816	CbGeAlD
Rosiglitazone—CYP2C19—liver—type 2 diabetes mellitus	6.43e-05	0.00809	CbGeAlD
Rosiglitazone—CYP2D6—kidney—type 2 diabetes mellitus	5.92e-05	0.00745	CbGeAlD
Rosiglitazone—CYP2C8—liver—type 2 diabetes mellitus	5.62e-05	0.00706	CbGeAlD
Rosiglitazone—CYP1A2—liver—type 2 diabetes mellitus	5.25e-05	0.00661	CbGeAlD
Rosiglitazone—CYP2C9—liver—type 2 diabetes mellitus	4.99e-05	0.00627	CbGeAlD
Rosiglitazone—Hepatobiliary disease—Irbesartan—type 2 diabetes mellitus	3.87e-05	0.000912	CcSEcCtD
Rosiglitazone—Immune system disorder—Valsartan—type 2 diabetes mellitus	3.86e-05	0.00091	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	3.86e-05	0.000909	CcSEcCtD
Rosiglitazone—Fatigue—Glimepiride—type 2 diabetes mellitus	3.85e-05	0.000907	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	3.84e-05	0.000906	CcSEcCtD
Rosiglitazone—Myalgia—Glyburide—type 2 diabetes mellitus	3.84e-05	0.000905	CcSEcCtD
Rosiglitazone—Arthralgia—Glyburide—type 2 diabetes mellitus	3.84e-05	0.000905	CcSEcCtD
Rosiglitazone—Fatigue—Sitagliptin—type 2 diabetes mellitus	3.84e-05	0.000904	CcSEcCtD
Rosiglitazone—Oedema peripheral—Metformin—type 2 diabetes mellitus	3.84e-05	0.000904	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Metformin—type 2 diabetes mellitus	3.83e-05	0.000902	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	3.82e-05	0.0009	CcSEcCtD
Rosiglitazone—Immune system disorder—Orlistat—type 2 diabetes mellitus	3.82e-05	0.0009	CcSEcCtD
Rosiglitazone—Constipation—Sitagliptin—type 2 diabetes mellitus	3.81e-05	0.000897	CcSEcCtD
Rosiglitazone—Urticaria—Glipizide—type 2 diabetes mellitus	3.8e-05	0.000896	CcSEcCtD
Rosiglitazone—Anaemia—Gliclazide—type 2 diabetes mellitus	3.75e-05	0.000883	CcSEcCtD
Rosiglitazone—CYP2D6—liver—type 2 diabetes mellitus	3.74e-05	0.00471	CbGeAlD
Rosiglitazone—Malnutrition—Valsartan—type 2 diabetes mellitus	3.72e-05	0.000877	CcSEcCtD
Rosiglitazone—Angioedema—Gliclazide—type 2 diabetes mellitus	3.7e-05	0.000873	CcSEcCtD
Rosiglitazone—Oedema—Glyburide—type 2 diabetes mellitus	3.68e-05	0.000868	CcSEcCtD
Rosiglitazone—Malnutrition—Orlistat—type 2 diabetes mellitus	3.68e-05	0.000867	CcSEcCtD
Rosiglitazone—Hepatitis—Irbesartan—type 2 diabetes mellitus	3.68e-05	0.000866	CcSEcCtD
Rosiglitazone—Rash—Repaglinide—type 2 diabetes mellitus	3.65e-05	0.000859	CcSEcCtD
Rosiglitazone—Dermatitis—Repaglinide—type 2 diabetes mellitus	3.64e-05	0.000859	CcSEcCtD
Rosiglitazone—Urticaria—Pioglitazone—type 2 diabetes mellitus	3.64e-05	0.000858	CcSEcCtD
Rosiglitazone—Eye disorder—Metformin—type 2 diabetes mellitus	3.64e-05	0.000858	CcSEcCtD
Rosiglitazone—Leukopenia—Gliclazide—type 2 diabetes mellitus	3.63e-05	0.000855	CcSEcCtD
Rosiglitazone—Headache—Repaglinide—type 2 diabetes mellitus	3.62e-05	0.000854	CcSEcCtD
Rosiglitazone—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	3.62e-05	0.000853	CcSEcCtD
Rosiglitazone—Sinusitis—Losartan—type 2 diabetes mellitus	3.62e-05	0.000852	CcSEcCtD
Rosiglitazone—Cardiac disorder—Metformin—type 2 diabetes mellitus	3.62e-05	0.000852	CcSEcCtD
Rosiglitazone—Nervous system disorder—Glyburide—type 2 diabetes mellitus	3.61e-05	0.000851	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	3.61e-05	0.000851	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	3.61e-05	0.00085	CcSEcCtD
Rosiglitazone—Back pain—Valsartan—type 2 diabetes mellitus	3.6e-05	0.000849	CcSEcCtD
Rosiglitazone—Back pain—Orlistat—type 2 diabetes mellitus	3.56e-05	0.000839	CcSEcCtD
Rosiglitazone—Urticaria—Glimepiride—type 2 diabetes mellitus	3.55e-05	0.000836	CcSEcCtD
Rosiglitazone—Urticaria—Sitagliptin—type 2 diabetes mellitus	3.54e-05	0.000833	CcSEcCtD
Rosiglitazone—Immune system disorder—Metformin—type 2 diabetes mellitus	3.52e-05	0.000829	CcSEcCtD
Rosiglitazone—Hypertension—Gliclazide—type 2 diabetes mellitus	3.5e-05	0.000824	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	3.48e-05	0.00082	CcSEcCtD
Rosiglitazone—Fatigue—Bromocriptine—type 2 diabetes mellitus	3.47e-05	0.000819	CcSEcCtD
Rosiglitazone—Hepatitis—Losartan—type 2 diabetes mellitus	3.46e-05	0.000815	CcSEcCtD
Rosiglitazone—Myalgia—Gliclazide—type 2 diabetes mellitus	3.45e-05	0.000813	CcSEcCtD
Rosiglitazone—Arthralgia—Gliclazide—type 2 diabetes mellitus	3.45e-05	0.000813	CcSEcCtD
Rosiglitazone—Constipation—Bromocriptine—type 2 diabetes mellitus	3.45e-05	0.000812	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	3.44e-05	0.000812	CcSEcCtD
Rosiglitazone—Nausea—Repaglinide—type 2 diabetes mellitus	3.44e-05	0.00081	CcSEcCtD
Rosiglitazone—Asthenia—Glipizide—type 2 diabetes mellitus	3.43e-05	0.000809	CcSEcCtD
Rosiglitazone—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	3.41e-05	0.000804	CcSEcCtD
Rosiglitazone—Angioedema—Valsartan—type 2 diabetes mellitus	3.4e-05	0.000802	CcSEcCtD
Rosiglitazone—Malnutrition—Metformin—type 2 diabetes mellitus	3.39e-05	0.000799	CcSEcCtD
Rosiglitazone—Pruritus—Glipizide—type 2 diabetes mellitus	3.39e-05	0.000798	CcSEcCtD
Rosiglitazone—Weight increased—Ramipril—type 2 diabetes mellitus	3.37e-05	0.000795	CcSEcCtD
Rosiglitazone—Angioedema—Orlistat—type 2 diabetes mellitus	3.36e-05	0.000792	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	3.36e-05	0.000791	CcSEcCtD
Rosiglitazone—Immune system disorder—Irbesartan—type 2 diabetes mellitus	3.32e-05	0.000782	CcSEcCtD
Rosiglitazone—Asthenia—Pioglitazone—type 2 diabetes mellitus	3.29e-05	0.000775	CcSEcCtD
Rosiglitazone—Infection—Gliclazide—type 2 diabetes mellitus	3.29e-05	0.000774	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	3.28e-05	0.000772	CcSEcCtD
Rosiglitazone—Diarrhoea—Glipizide—type 2 diabetes mellitus	3.28e-05	0.000772	CcSEcCtD
Rosiglitazone—Erythema multiforme—Losartan—type 2 diabetes mellitus	3.27e-05	0.000771	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	3.26e-05	0.000768	CcSEcCtD
Rosiglitazone—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	3.24e-05	0.000764	CcSEcCtD
Rosiglitazone—Myocardial infarction—Ramipril—type 2 diabetes mellitus	3.24e-05	0.000763	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	3.24e-05	0.000763	CcSEcCtD
Rosiglitazone—Asthenia—Glimepiride—type 2 diabetes mellitus	3.2e-05	0.000755	CcSEcCtD
Rosiglitazone—Urticaria—Bromocriptine—type 2 diabetes mellitus	3.2e-05	0.000754	CcSEcCtD
Rosiglitazone—Malnutrition—Irbesartan—type 2 diabetes mellitus	3.2e-05	0.000754	CcSEcCtD
Rosiglitazone—Asthenia—Sitagliptin—type 2 diabetes mellitus	3.19e-05	0.000753	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	3.18e-05	0.000749	CcSEcCtD
Rosiglitazone—Arthralgia—Valsartan—type 2 diabetes mellitus	3.17e-05	0.000747	CcSEcCtD
Rosiglitazone—Myalgia—Valsartan—type 2 diabetes mellitus	3.17e-05	0.000747	CcSEcCtD
Rosiglitazone—Dizziness—Glipizide—type 2 diabetes mellitus	3.17e-05	0.000746	CcSEcCtD
Rosiglitazone—Pruritus—Glimepiride—type 2 diabetes mellitus	3.16e-05	0.000745	CcSEcCtD
Rosiglitazone—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	3.14e-05	0.000739	CcSEcCtD
Rosiglitazone—Myalgia—Orlistat—type 2 diabetes mellitus	3.13e-05	0.000738	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	3.13e-05	0.000736	CcSEcCtD
Rosiglitazone—Sinusitis—Ramipril—type 2 diabetes mellitus	3.1e-05	0.00073	CcSEcCtD
Rosiglitazone—Diarrhoea—Glimepiride—type 2 diabetes mellitus	3.06e-05	0.00072	CcSEcCtD
Rosiglitazone—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	3.05e-05	0.000718	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	3.04e-05	0.000716	CcSEcCtD
Rosiglitazone—Oedema—Valsartan—type 2 diabetes mellitus	3.04e-05	0.000716	CcSEcCtD
Rosiglitazone—Dizziness—Pioglitazone—type 2 diabetes mellitus	3.03e-05	0.000714	CcSEcCtD
Rosiglitazone—Infection—Valsartan—type 2 diabetes mellitus	3.02e-05	0.000711	CcSEcCtD
Rosiglitazone—Rash—Glipizide—type 2 diabetes mellitus	3.02e-05	0.000711	CcSEcCtD
Rosiglitazone—Dermatitis—Glipizide—type 2 diabetes mellitus	3.02e-05	0.00071	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	3.01e-05	0.00071	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	3e-05	0.000708	CcSEcCtD
Rosiglitazone—Oedema—Orlistat—type 2 diabetes mellitus	3e-05	0.000708	CcSEcCtD
Rosiglitazone—Headache—Glipizide—type 2 diabetes mellitus	3e-05	0.000707	CcSEcCtD
Rosiglitazone—Infection—Orlistat—type 2 diabetes mellitus	2.98e-05	0.000703	CcSEcCtD
Rosiglitazone—Nervous system disorder—Valsartan—type 2 diabetes mellitus	2.98e-05	0.000702	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	2.98e-05	0.000701	CcSEcCtD
Rosiglitazone—Hepatitis—Ramipril—type 2 diabetes mellitus	2.97e-05	0.000699	CcSEcCtD
Rosiglitazone—Anaemia—Irbesartan—type 2 diabetes mellitus	2.96e-05	0.000697	CcSEcCtD
Rosiglitazone—Dizziness—Glimepiride—type 2 diabetes mellitus	2.95e-05	0.000696	CcSEcCtD
Rosiglitazone—Nervous system disorder—Orlistat—type 2 diabetes mellitus	2.94e-05	0.000694	CcSEcCtD
Rosiglitazone—Dizziness—Sitagliptin—type 2 diabetes mellitus	2.94e-05	0.000694	CcSEcCtD
Rosiglitazone—Hypertension—Metformin—type 2 diabetes mellitus	2.93e-05	0.00069	CcSEcCtD
Rosiglitazone—Urticaria—Glyburide—type 2 diabetes mellitus	2.93e-05	0.00069	CcSEcCtD
Rosiglitazone—Angioedema—Irbesartan—type 2 diabetes mellitus	2.92e-05	0.000689	CcSEcCtD
Rosiglitazone—Oedema peripheral—Ramipril—type 2 diabetes mellitus	2.92e-05	0.000689	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	2.92e-05	0.000687	CcSEcCtD
Rosiglitazone—Back pain—Losartan—type 2 diabetes mellitus	2.91e-05	0.000686	CcSEcCtD
Rosiglitazone—Asthenia—Bromocriptine—type 2 diabetes mellitus	2.89e-05	0.000681	CcSEcCtD
Rosiglitazone—Myalgia—Metformin—type 2 diabetes mellitus	2.89e-05	0.00068	CcSEcCtD
Rosiglitazone—Headache—Pioglitazone—type 2 diabetes mellitus	2.87e-05	0.000677	CcSEcCtD
Rosiglitazone—Leukopenia—Irbesartan—type 2 diabetes mellitus	2.86e-05	0.000675	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	2.86e-05	0.000673	CcSEcCtD
Rosiglitazone—Fatigue—Gliclazide—type 2 diabetes mellitus	2.85e-05	0.000672	CcSEcCtD
Rosiglitazone—Nausea—Glipizide—type 2 diabetes mellitus	2.84e-05	0.00067	CcSEcCtD
Rosiglitazone—Constipation—Gliclazide—type 2 diabetes mellitus	2.83e-05	0.000666	CcSEcCtD
Rosiglitazone—Rash—Glimepiride—type 2 diabetes mellitus	2.82e-05	0.000664	CcSEcCtD
Rosiglitazone—Dermatitis—Glimepiride—type 2 diabetes mellitus	2.81e-05	0.000663	CcSEcCtD
Rosiglitazone—Rash—Sitagliptin—type 2 diabetes mellitus	2.81e-05	0.000661	CcSEcCtD
Rosiglitazone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	2.8e-05	0.000661	CcSEcCtD
Rosiglitazone—Erythema multiforme—Ramipril—type 2 diabetes mellitus	2.8e-05	0.000661	CcSEcCtD
Rosiglitazone—Headache—Glimepiride—type 2 diabetes mellitus	2.8e-05	0.000659	CcSEcCtD
Rosiglitazone—Headache—Sitagliptin—type 2 diabetes mellitus	2.79e-05	0.000657	CcSEcCtD
Rosiglitazone—Anaemia—Losartan—type 2 diabetes mellitus	2.78e-05	0.000656	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	2.77e-05	0.000652	CcSEcCtD
Rosiglitazone—Oedema—Metformin—type 2 diabetes mellitus	2.77e-05	0.000652	CcSEcCtD
Rosiglitazone—Hypertension—Irbesartan—type 2 diabetes mellitus	2.76e-05	0.000651	CcSEcCtD
Rosiglitazone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	2.76e-05	0.00065	CcSEcCtD
Rosiglitazone—Angioedema—Losartan—type 2 diabetes mellitus	2.75e-05	0.000648	CcSEcCtD
Rosiglitazone—Infection—Metformin—type 2 diabetes mellitus	2.75e-05	0.000648	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	2.74e-05	0.000645	CcSEcCtD
Rosiglitazone—Myalgia—Irbesartan—type 2 diabetes mellitus	2.72e-05	0.000642	CcSEcCtD
Rosiglitazone—Arthralgia—Irbesartan—type 2 diabetes mellitus	2.72e-05	0.000642	CcSEcCtD
Rosiglitazone—Nervous system disorder—Metformin—type 2 diabetes mellitus	2.71e-05	0.000639	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Metformin—type 2 diabetes mellitus	2.71e-05	0.000638	CcSEcCtD
Rosiglitazone—Leukopenia—Losartan—type 2 diabetes mellitus	2.7e-05	0.000635	CcSEcCtD
Rosiglitazone—Immune system disorder—Ramipril—type 2 diabetes mellitus	2.68e-05	0.000631	CcSEcCtD
Rosiglitazone—Dizziness—Bromocriptine—type 2 diabetes mellitus	2.66e-05	0.000628	CcSEcCtD
Rosiglitazone—Nausea—Glimepiride—type 2 diabetes mellitus	2.65e-05	0.000625	CcSEcCtD
Rosiglitazone—Nausea—Sitagliptin—type 2 diabetes mellitus	2.64e-05	0.000623	CcSEcCtD
Rosiglitazone—Asthenia—Glyburide—type 2 diabetes mellitus	2.64e-05	0.000623	CcSEcCtD
Rosiglitazone—Urticaria—Gliclazide—type 2 diabetes mellitus	2.63e-05	0.000619	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	2.62e-05	0.000618	CcSEcCtD
Rosiglitazone—Fatigue—Valsartan—type 2 diabetes mellitus	2.62e-05	0.000617	CcSEcCtD
Rosiglitazone—Oedema—Irbesartan—type 2 diabetes mellitus	2.61e-05	0.000615	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	2.61e-05	0.000615	CcSEcCtD
Rosiglitazone—Pruritus—Glyburide—type 2 diabetes mellitus	2.61e-05	0.000614	CcSEcCtD
Rosiglitazone—Constipation—Valsartan—type 2 diabetes mellitus	2.6e-05	0.000612	CcSEcCtD
Rosiglitazone—Infection—Irbesartan—type 2 diabetes mellitus	2.59e-05	0.000611	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	2.59e-05	0.000611	CcSEcCtD
Rosiglitazone—Fatigue—Orlistat—type 2 diabetes mellitus	2.59e-05	0.00061	CcSEcCtD
Rosiglitazone—Malnutrition—Ramipril—type 2 diabetes mellitus	2.58e-05	0.000608	CcSEcCtD
Rosiglitazone—Myalgia—Losartan—type 2 diabetes mellitus	2.56e-05	0.000604	CcSEcCtD
Rosiglitazone—Arthralgia—Losartan—type 2 diabetes mellitus	2.56e-05	0.000604	CcSEcCtD
Rosiglitazone—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	2.56e-05	0.000603	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	2.56e-05	0.000602	CcSEcCtD
Rosiglitazone—Rash—Bromocriptine—type 2 diabetes mellitus	2.54e-05	0.000599	CcSEcCtD
Rosiglitazone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	2.54e-05	0.000598	CcSEcCtD
Rosiglitazone—Headache—Bromocriptine—type 2 diabetes mellitus	2.52e-05	0.000595	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	2.52e-05	0.000594	CcSEcCtD
Rosiglitazone—Diarrhoea—Glyburide—type 2 diabetes mellitus	2.52e-05	0.000594	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Losartan—type 2 diabetes mellitus	2.46e-05	0.000579	CcSEcCtD
Rosiglitazone—Oedema—Losartan—type 2 diabetes mellitus	2.46e-05	0.000579	CcSEcCtD
Rosiglitazone—Infection—Losartan—type 2 diabetes mellitus	2.44e-05	0.000575	CcSEcCtD
Rosiglitazone—Urticaria—Valsartan—type 2 diabetes mellitus	2.41e-05	0.000569	CcSEcCtD
Rosiglitazone—Nervous system disorder—Losartan—type 2 diabetes mellitus	2.41e-05	0.000568	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Losartan—type 2 diabetes mellitus	2.41e-05	0.000567	CcSEcCtD
Rosiglitazone—Nausea—Bromocriptine—type 2 diabetes mellitus	2.39e-05	0.000564	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	2.39e-05	0.000563	CcSEcCtD
Rosiglitazone—Fatigue—Metformin—type 2 diabetes mellitus	2.39e-05	0.000562	CcSEcCtD
Rosiglitazone—Urticaria—Orlistat—type 2 diabetes mellitus	2.39e-05	0.000562	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	2.38e-05	0.000561	CcSEcCtD
Rosiglitazone—Asthenia—Gliclazide—type 2 diabetes mellitus	2.37e-05	0.000559	CcSEcCtD
Rosiglitazone—Constipation—Metformin—type 2 diabetes mellitus	2.37e-05	0.000558	CcSEcCtD
Rosiglitazone—Angioedema—Ramipril—type 2 diabetes mellitus	2.36e-05	0.000556	CcSEcCtD
Rosiglitazone—Pruritus—Gliclazide—type 2 diabetes mellitus	2.34e-05	0.000551	CcSEcCtD
Rosiglitazone—Rash—Glyburide—type 2 diabetes mellitus	2.32e-05	0.000547	CcSEcCtD
Rosiglitazone—Dermatitis—Glyburide—type 2 diabetes mellitus	2.32e-05	0.000547	CcSEcCtD
Rosiglitazone—Leukopenia—Ramipril—type 2 diabetes mellitus	2.31e-05	0.000545	CcSEcCtD
Rosiglitazone—Headache—Glyburide—type 2 diabetes mellitus	2.31e-05	0.000544	CcSEcCtD
Rosiglitazone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	2.26e-05	0.000533	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	2.25e-05	0.000531	CcSEcCtD
Rosiglitazone—Fatigue—Irbesartan—type 2 diabetes mellitus	2.25e-05	0.000531	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	2.24e-05	0.000528	CcSEcCtD
Rosiglitazone—Constipation—Irbesartan—type 2 diabetes mellitus	2.23e-05	0.000526	CcSEcCtD
Rosiglitazone—Urticaria—Metformin—type 2 diabetes mellitus	2.2e-05	0.000518	CcSEcCtD
Rosiglitazone—Arthralgia—Ramipril—type 2 diabetes mellitus	2.2e-05	0.000518	CcSEcCtD
Rosiglitazone—Myalgia—Ramipril—type 2 diabetes mellitus	2.2e-05	0.000518	CcSEcCtD
Rosiglitazone—Nausea—Glyburide—type 2 diabetes mellitus	2.19e-05	0.000516	CcSEcCtD
Rosiglitazone—Dizziness—Gliclazide—type 2 diabetes mellitus	2.19e-05	0.000515	CcSEcCtD
Rosiglitazone—Asthenia—Valsartan—type 2 diabetes mellitus	2.18e-05	0.000514	CcSEcCtD
Rosiglitazone—Asthenia—Orlistat—type 2 diabetes mellitus	2.15e-05	0.000508	CcSEcCtD
Rosiglitazone—Pruritus—Valsartan—type 2 diabetes mellitus	2.15e-05	0.000507	CcSEcCtD
Rosiglitazone—Pruritus—Orlistat—type 2 diabetes mellitus	2.12e-05	0.000501	CcSEcCtD
Rosiglitazone—Fatigue—Losartan—type 2 diabetes mellitus	2.12e-05	0.000499	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	2.11e-05	0.000497	CcSEcCtD
Rosiglitazone—Oedema—Ramipril—type 2 diabetes mellitus	2.11e-05	0.000497	CcSEcCtD
Rosiglitazone—Constipation—Losartan—type 2 diabetes mellitus	2.1e-05	0.000495	CcSEcCtD
Rosiglitazone—Rash—Gliclazide—type 2 diabetes mellitus	2.09e-05	0.000491	CcSEcCtD
Rosiglitazone—Dermatitis—Gliclazide—type 2 diabetes mellitus	2.08e-05	0.000491	CcSEcCtD
Rosiglitazone—Diarrhoea—Valsartan—type 2 diabetes mellitus	2.08e-05	0.00049	CcSEcCtD
Rosiglitazone—Urticaria—Irbesartan—type 2 diabetes mellitus	2.07e-05	0.000489	CcSEcCtD
Rosiglitazone—Headache—Gliclazide—type 2 diabetes mellitus	2.07e-05	0.000488	CcSEcCtD
Rosiglitazone—Nervous system disorder—Ramipril—type 2 diabetes mellitus	2.07e-05	0.000487	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	2.06e-05	0.000486	CcSEcCtD
Rosiglitazone—Diarrhoea—Orlistat—type 2 diabetes mellitus	2.05e-05	0.000484	CcSEcCtD
Rosiglitazone—Dizziness—Valsartan—type 2 diabetes mellitus	2.01e-05	0.000473	CcSEcCtD
Rosiglitazone—Dizziness—Orlistat—type 2 diabetes mellitus	1.99e-05	0.000468	CcSEcCtD
Rosiglitazone—Asthenia—Metformin—type 2 diabetes mellitus	1.99e-05	0.000468	CcSEcCtD
Rosiglitazone—Nausea—Gliclazide—type 2 diabetes mellitus	1.96e-05	0.000463	CcSEcCtD
Rosiglitazone—Pruritus—Metformin—type 2 diabetes mellitus	1.96e-05	0.000461	CcSEcCtD
Rosiglitazone—Urticaria—Losartan—type 2 diabetes mellitus	1.95e-05	0.00046	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	1.92e-05	0.000452	CcSEcCtD
Rosiglitazone—Rash—Valsartan—type 2 diabetes mellitus	1.92e-05	0.000451	CcSEcCtD
Rosiglitazone—Dermatitis—Valsartan—type 2 diabetes mellitus	1.91e-05	0.000451	CcSEcCtD
Rosiglitazone—Headache—Valsartan—type 2 diabetes mellitus	1.9e-05	0.000449	CcSEcCtD
Rosiglitazone—Diarrhoea—Metformin—type 2 diabetes mellitus	1.89e-05	0.000446	CcSEcCtD
Rosiglitazone—Rash—Orlistat—type 2 diabetes mellitus	1.89e-05	0.000446	CcSEcCtD
Rosiglitazone—Dermatitis—Orlistat—type 2 diabetes mellitus	1.89e-05	0.000446	CcSEcCtD
Rosiglitazone—Headache—Orlistat—type 2 diabetes mellitus	1.88e-05	0.000443	CcSEcCtD
Rosiglitazone—Asthenia—Irbesartan—type 2 diabetes mellitus	1.87e-05	0.000441	CcSEcCtD
Rosiglitazone—Pruritus—Irbesartan—type 2 diabetes mellitus	1.85e-05	0.000435	CcSEcCtD
Rosiglitazone—Dizziness—Metformin—type 2 diabetes mellitus	1.83e-05	0.000431	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	1.82e-05	0.000429	CcSEcCtD
Rosiglitazone—Fatigue—Ramipril—type 2 diabetes mellitus	1.82e-05	0.000428	CcSEcCtD
Rosiglitazone—Nausea—Valsartan—type 2 diabetes mellitus	1.81e-05	0.000425	CcSEcCtD
Rosiglitazone—Constipation—Ramipril—type 2 diabetes mellitus	1.8e-05	0.000425	CcSEcCtD
Rosiglitazone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	1.79e-05	0.000421	CcSEcCtD
Rosiglitazone—Nausea—Orlistat—type 2 diabetes mellitus	1.78e-05	0.00042	CcSEcCtD
Rosiglitazone—Asthenia—Losartan—type 2 diabetes mellitus	1.76e-05	0.000415	CcSEcCtD
Rosiglitazone—Rash—Metformin—type 2 diabetes mellitus	1.74e-05	0.000411	CcSEcCtD
Rosiglitazone—Dermatitis—Metformin—type 2 diabetes mellitus	1.74e-05	0.000411	CcSEcCtD
Rosiglitazone—Pruritus—Losartan—type 2 diabetes mellitus	1.74e-05	0.00041	CcSEcCtD
Rosiglitazone—Headache—Metformin—type 2 diabetes mellitus	1.73e-05	0.000408	CcSEcCtD
Rosiglitazone—Dizziness—Irbesartan—type 2 diabetes mellitus	1.73e-05	0.000407	CcSEcCtD
Rosiglitazone—Diarrhoea—Losartan—type 2 diabetes mellitus	1.68e-05	0.000396	CcSEcCtD
Rosiglitazone—Urticaria—Ramipril—type 2 diabetes mellitus	1.67e-05	0.000394	CcSEcCtD
Rosiglitazone—Rash—Irbesartan—type 2 diabetes mellitus	1.65e-05	0.000388	CcSEcCtD
Rosiglitazone—Dermatitis—Irbesartan—type 2 diabetes mellitus	1.65e-05	0.000388	CcSEcCtD
Rosiglitazone—Nausea—Metformin—type 2 diabetes mellitus	1.64e-05	0.000387	CcSEcCtD
Rosiglitazone—Headache—Irbesartan—type 2 diabetes mellitus	1.64e-05	0.000385	CcSEcCtD
Rosiglitazone—Dizziness—Losartan—type 2 diabetes mellitus	1.63e-05	0.000383	CcSEcCtD
Rosiglitazone—Nausea—Irbesartan—type 2 diabetes mellitus	1.55e-05	0.000366	CcSEcCtD
Rosiglitazone—Rash—Losartan—type 2 diabetes mellitus	1.55e-05	0.000365	CcSEcCtD
Rosiglitazone—Dermatitis—Losartan—type 2 diabetes mellitus	1.55e-05	0.000365	CcSEcCtD
Rosiglitazone—Headache—Losartan—type 2 diabetes mellitus	1.54e-05	0.000363	CcSEcCtD
Rosiglitazone—Asthenia—Ramipril—type 2 diabetes mellitus	1.51e-05	0.000356	CcSEcCtD
Rosiglitazone—Pruritus—Ramipril—type 2 diabetes mellitus	1.49e-05	0.000351	CcSEcCtD
Rosiglitazone—Nausea—Losartan—type 2 diabetes mellitus	1.46e-05	0.000344	CcSEcCtD
Rosiglitazone—Diarrhoea—Ramipril—type 2 diabetes mellitus	1.44e-05	0.00034	CcSEcCtD
Rosiglitazone—Dizziness—Ramipril—type 2 diabetes mellitus	1.39e-05	0.000328	CcSEcCtD
Rosiglitazone—Rash—Ramipril—type 2 diabetes mellitus	1.33e-05	0.000313	CcSEcCtD
Rosiglitazone—Dermatitis—Ramipril—type 2 diabetes mellitus	1.33e-05	0.000313	CcSEcCtD
Rosiglitazone—Headache—Ramipril—type 2 diabetes mellitus	1.32e-05	0.000311	CcSEcCtD
Rosiglitazone—Nausea—Ramipril—type 2 diabetes mellitus	1.25e-05	0.000295	CcSEcCtD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.02e-06	4.06e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PPARA—type 2 diabetes mellitus	1.02e-06	4.05e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.02e-06	4.04e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	1.01e-06	4.04e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	1.01e-06	4.04e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	1.01e-06	4.03e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	1.01e-06	4.02e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.01e-06	4.02e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	1.01e-06	4.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	1e-06	4e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	1e-06	4e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	1e-06	4e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PPARG—type 2 diabetes mellitus	1e-06	3.98e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTGS2—type 2 diabetes mellitus	9.99e-07	3.98e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GCG—type 2 diabetes mellitus	9.98e-07	3.97e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	9.98e-07	3.97e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	9.91e-07	3.95e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AGT—type 2 diabetes mellitus	9.86e-07	3.93e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	9.83e-07	3.92e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—INS—type 2 diabetes mellitus	9.81e-07	3.91e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CALM1—type 2 diabetes mellitus	9.7e-07	3.86e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—APOE—type 2 diabetes mellitus	9.66e-07	3.85e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—APOA1—type 2 diabetes mellitus	9.55e-07	3.8e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	9.5e-07	3.78e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	9.5e-07	3.78e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	9.5e-07	3.78e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	9.45e-07	3.76e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	9.45e-07	3.76e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	9.42e-07	3.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	9.42e-07	3.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	9.42e-07	3.75e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	9.4e-07	3.74e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	9.34e-07	3.72e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	9.34e-07	3.72e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	9.33e-07	3.71e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	9.24e-07	3.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	9.24e-07	3.68e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	9.21e-07	3.67e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	9.21e-07	3.67e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	9.16e-07	3.65e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	9.11e-07	3.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	9.06e-07	3.61e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	9.04e-07	3.6e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	9.04e-07	3.6e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	9.03e-07	3.6e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ALB—type 2 diabetes mellitus	9e-07	3.58e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	8.98e-07	3.57e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	8.97e-07	3.57e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	8.97e-07	3.57e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	8.97e-07	3.57e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—SRC—type 2 diabetes mellitus	8.97e-07	3.57e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	8.97e-07	3.57e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	8.96e-07	3.57e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	8.96e-07	3.57e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	8.92e-07	3.55e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	8.9e-07	3.54e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	8.76e-07	3.49e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	8.74e-07	3.48e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—INS—type 2 diabetes mellitus	8.73e-07	3.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	8.69e-07	3.46e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	8.66e-07	3.45e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	8.65e-07	3.44e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.65e-07	3.44e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	8.61e-07	3.43e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	8.61e-07	3.43e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	8.6e-07	3.43e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	8.6e-07	3.43e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GNB3—type 2 diabetes mellitus	8.6e-07	3.42e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.6e-07	3.42e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	8.59e-07	3.42e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	8.59e-07	3.42e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	8.56e-07	3.41e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	8.52e-07	3.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	8.52e-07	3.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	8.49e-07	3.38e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CAT—type 2 diabetes mellitus	8.45e-07	3.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	8.42e-07	3.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	8.38e-07	3.34e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	8.31e-07	3.31e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	8.26e-07	3.29e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	8.25e-07	3.29e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	8.25e-07	3.28e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	8.24e-07	3.28e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	8.24e-07	3.28e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOB—type 2 diabetes mellitus	8.2e-07	3.26e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	8.17e-07	3.25e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	8.17e-07	3.25e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	8.07e-07	3.21e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	8.05e-07	3.2e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	8.05e-07	3.2e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	8.05e-07	3.2e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	8.02e-07	3.19e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	8.02e-07	3.19e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	8e-07	3.19e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	7.98e-07	3.18e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	7.9e-07	3.15e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	7.87e-07	3.13e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	7.87e-07	3.13e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	7.83e-07	3.12e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—LPL—type 2 diabetes mellitus	7.83e-07	3.12e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.72e-07	3.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.72e-07	3.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	7.72e-07	3.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	7.71e-07	3.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	7.68e-07	3.06e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	7.68e-07	3.06e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	7.66e-07	3.05e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	7.66e-07	3.05e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	7.65e-07	3.05e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	7.65e-07	3.05e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GPX1—type 2 diabetes mellitus	7.64e-07	3.04e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	7.58e-07	3.02e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	7.57e-07	3.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	7.48e-07	2.98e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CD36—type 2 diabetes mellitus	7.44e-07	2.96e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	7.39e-07	2.94e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	7.36e-07	2.93e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	7.36e-07	2.93e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	7.35e-07	2.92e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	7.28e-07	2.9e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	7.24e-07	2.88e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	7.24e-07	2.88e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	7.16e-07	2.85e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	7.1e-07	2.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.1e-07	2.83e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	7.1e-07	2.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	7.09e-07	2.82e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	7.07e-07	2.81e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	7.06e-07	2.81e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	7.05e-07	2.81e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.04e-07	2.8e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	7.04e-07	2.8e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	7.03e-07	2.8e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	7.01e-07	2.79e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	7e-07	2.79e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	6.98e-07	2.78e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	6.98e-07	2.78e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	6.97e-07	2.78e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	6.95e-07	2.77e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPARA—type 2 diabetes mellitus	6.92e-07	2.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	6.91e-07	2.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	6.88e-07	2.74e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	6.86e-07	2.73e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	6.77e-07	2.7e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	6.74e-07	2.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	6.71e-07	2.67e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AGT—type 2 diabetes mellitus	6.7e-07	2.67e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	6.68e-07	2.66e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	6.62e-07	2.64e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	6.62e-07	2.64e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	6.6e-07	2.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	6.59e-07	2.63e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CALM1—type 2 diabetes mellitus	6.59e-07	2.62e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	6.59e-07	2.62e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOE—type 2 diabetes mellitus	6.56e-07	2.61e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	6.53e-07	2.6e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	6.52e-07	2.6e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOA1—type 2 diabetes mellitus	6.49e-07	2.58e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	6.46e-07	2.57e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—AKT1—type 2 diabetes mellitus	6.46e-07	2.57e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	6.41e-07	2.55e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	6.33e-07	2.52e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	6.33e-07	2.52e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	6.31e-07	2.51e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	6.27e-07	2.5e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	6.25e-07	2.49e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	6.21e-07	2.47e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	6.14e-07	2.45e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	6.09e-07	2.42e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	6.06e-07	2.41e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	6.01e-07	2.39e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.01e-07	2.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	6.01e-07	2.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	6.01e-07	2.39e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	5.99e-07	2.38e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	5.91e-07	2.35e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	5.91e-07	2.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	5.89e-07	2.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	5.82e-07	2.32e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	5.82e-07	2.32e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	5.77e-07	2.3e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	5.75e-07	2.29e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	5.73e-07	2.28e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPARG—type 2 diabetes mellitus	5.72e-07	2.28e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	5.71e-07	2.27e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	5.66e-07	2.25e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	5.64e-07	2.24e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—INS—type 2 diabetes mellitus	5.61e-07	2.23e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	5.58e-07	2.22e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	5.57e-07	2.22e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	5.53e-07	2.2e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	5.48e-07	2.18e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	5.48e-07	2.18e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	5.44e-07	2.16e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	5.42e-07	2.16e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	5.39e-07	2.15e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	5.37e-07	2.14e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	5.36e-07	2.13e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	5.36e-07	2.13e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	5.34e-07	2.13e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	5.31e-07	2.11e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	5.2e-07	2.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	5.17e-07	2.06e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	5.14e-07	2.05e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	5.13e-07	2.04e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	5.03e-07	2e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—AKT1—type 2 diabetes mellitus	5.02e-07	2e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	4.94e-07	1.97e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	4.94e-07	1.97e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	4.93e-07	1.96e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	4.92e-07	1.96e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—NOS3—type 2 diabetes mellitus	4.92e-07	1.96e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	4.84e-07	1.93e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	4.72e-07	1.88e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	4.68e-07	1.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	4.68e-07	1.86e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	4.63e-07	1.84e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	4.61e-07	1.84e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	4.61e-07	1.83e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	4.59e-07	1.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	4.59e-07	1.83e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	4.54e-07	1.81e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	4.52e-07	1.8e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	4.5e-07	1.79e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	4.41e-07	1.76e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	4.41e-07	1.76e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	4.24e-07	1.69e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	4.21e-07	1.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	4.06e-07	1.62e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	4.06e-07	1.62e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	4.04e-07	1.61e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	4.02e-07	1.6e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	4.02e-07	1.6e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	4e-07	1.59e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	3.96e-07	1.57e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	3.92e-07	1.56e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	3.71e-07	1.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	3.68e-07	1.47e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	3.59e-07	1.43e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	3.52e-07	1.4e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	3.44e-07	1.37e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.44e-07	1.37e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	3.33e-07	1.32e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	3.14e-07	1.25e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	2.27e-07	9.05e-06	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AKT1—type 2 diabetes mellitus	2.26e-07	9e-06	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	2.03e-07	8.08e-06	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.87e-07	7.43e-06	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.85e-07	7.37e-06	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.58e-07	6.29e-06	CbGpPWpGaD
